43 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 Nov 23
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
6:01am
at the upcoming American Society of Nephrology and the American College of Rheumatology being held in November 2023. Led by several leading experts
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
3 Nov 22
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results
6:04am
, including LUPUS, the American College of Rheumatology Convergence 2022, and, the American Society of Nephrology.
Key ongoing clinical updates for LUPKYNIS
8-K
EX-99.1
ec4ocb
3 Nov 21
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
12:00am
DEF 14A
5giarpe twv56
10 May 21
Definitive proxy
4:06pm
10-K/A
y3wk fd4sojf2
30 Apr 21
Annual report (amended)
4:16pm
PRE 14A
2utc3rl xj06d
27 Apr 21
Preliminary proxy
4:32pm
10-K
EX-10.18
o0rkf6
24 Feb 21
Annual report
4:09pm
10-K
EX-10.14
8pd xrbwdrwl7ihobd
24 Feb 21
Annual report
4:09pm
10-K
EX-10.15
6x3ag05 w9beinb9v95
24 Feb 21
Annual report
4:09pm
6-K
EX-99.1
hp0sn20pid3w8 iblq2b
22 Oct 20
Aurinia Pharmaceuticals Inc. 6-K
5:15pm
SUPPL
jeo6 h9kay
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
41wpxt
26 Jun 20
Supplemental materials (foreign)
4:08pm
F-10/A
6y6 5s5cb
17 Jun 20
Registration of securities (Canada) (amended)
4:35pm
F-10
9n8yi 4ml74ctqot6o
29 May 20
Registration of securities (Canada)
4:07pm
6-K
EX-99.3
m5w3i
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
40-F
EX-99.1
zfvga55o
5 Mar 20
Annual report (Canada)
4:06pm